These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17416753

  • 21. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions.
    Li J, Kleeff J, Esposito I, Kayed H, Felix K, Giese T, Büchler MW, Friess H.
    J Histochem Cytochem; 2005 Jul; 53(7):885-93. PubMed ID: 15995147
    [Abstract] [Full Text] [Related]

  • 22. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, Anderson MA, Bamberger AM, Greenson J, Brand RE, Ramachandran V, Logsdon CD.
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [Abstract] [Full Text] [Related]

  • 23. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
    Uno K, Azuma T, Nakajima M, Yasuda K, Hayakumo T, Mukai H, Sakai T, Kawai K.
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
    [Abstract] [Full Text] [Related]

  • 24. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.
    Beger C, Ramadani M, Meyer S, Leder G, Krüger M, Welte K, Gansauge F, Beger HG.
    Clin Cancer Res; 2004 Jun 01; 10(11):3780-7. PubMed ID: 15173085
    [Abstract] [Full Text] [Related]

  • 25. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
    Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T.
    Cancer Res; 2007 Sep 15; 67(18):8633-42. PubMed ID: 17875703
    [Abstract] [Full Text] [Related]

  • 26. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N, Mizumoto K, Tanaka M, Niiyama H, Yokohata K, Tominaga Y, Shimura H, Muta T, Hamasaki N.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [Abstract] [Full Text] [Related]

  • 27. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas.
    Hong SP, Lee EK, Park JY, Jeon TJ, Bang S, Park S, Chung JB, Lee WJ, Kim H, Song SY.
    Oncol Rep; 2009 Jan 15; 21(1):19-24. PubMed ID: 19082438
    [Abstract] [Full Text] [Related]

  • 28. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 15; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 29. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
    Nakashima A, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Oda M, Sueda T, Hiyama E.
    Pancreas; 2009 Jul 15; 38(5):527-33. PubMed ID: 19342980
    [Abstract] [Full Text] [Related]

  • 30. Uroguanylin inhibits proliferation of pancreatic cancer cells.
    Kloeters O, Friess H, Giese N, Buechler MW, Cetin Y, Kulaksiz H.
    Scand J Gastroenterol; 2008 Jul 15; 43(4):447-55. PubMed ID: 18365910
    [Abstract] [Full Text] [Related]

  • 31. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
    Gold DV, Karanjawala Z, Modrak DE, Goldenberg DM, Hruban RH.
    Clin Cancer Res; 2007 Dec 15; 13(24):7380-7. PubMed ID: 18094420
    [Abstract] [Full Text] [Related]

  • 32. [Clinical significance of the expression of MUC4 mRNA in peripheral blood mononuclear cells of pancreatic cancer patients].
    Li XH, Xiong JX, Wang CY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct 15; 27(5):624-7. PubMed ID: 16274046
    [Abstract] [Full Text] [Related]

  • 33. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.
    Maire F, Voitot H, Aubert A, Palazzo L, O'Toole D, Couvelard A, Levy P, Vidaud M, Sauvanet A, Ruszniewski P, Hammel P.
    Am J Gastroenterol; 2008 Nov 15; 103(11):2871-7. PubMed ID: 18775021
    [Abstract] [Full Text] [Related]

  • 34. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
    Uehara H, Nakaizumi A, Iishi H, Takenaka A, Eguchi H, Ohigashi H, Ishikawa O.
    Pancreas; 2008 Apr 15; 36(3):236-40. PubMed ID: 18362835
    [Abstract] [Full Text] [Related]

  • 35. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
    Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP, Lemoine NR.
    J Pathol; 2003 Sep 15; 201(1):63-74. PubMed ID: 12950018
    [Abstract] [Full Text] [Related]

  • 36. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.
    Pancreas; 2008 Jan 15; 36(1):50-5. PubMed ID: 18192881
    [Abstract] [Full Text] [Related]

  • 37. Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer.
    Yamada D, Ohuchida K, Mizumoto K, Ohhashi S, Yu J, Egami T, Fujita H, Nagai E, Tanaka M.
    Anticancer Res; 2007 Jan 15; 27(2):793-9. PubMed ID: 17465204
    [Abstract] [Full Text] [Related]

  • 38. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T, Shimamoto F, Hiyama E.
    J Surg Oncol; 2008 Apr 01; 97(5):469-75. PubMed ID: 18161862
    [Abstract] [Full Text] [Related]

  • 39. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H.
    Arch Surg; 2009 Apr 01; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [Abstract] [Full Text] [Related]

  • 40. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T.
    J Surg Oncol; 2009 Jul 01; 100(1):13-8. PubMed ID: 19384908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.